Olga Czabak
Lublin, LU, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial.
Journal: The Lancet. Haematology
Published: November 21, 2025
Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone.
Journal: Polish archives of internal medicine
Published: May 15, 2024
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.
Journal: British journal of haematology
Published: June 28, 2023
Efficacy of ixazomib-lenalidomide-dexamethasone in high-molecular-risk relapsed/refractory multiple myeloma - case series and literature review.
Journal: Annals of agricultural and environmental medicine : AAEM
Published: March 30, 2022
RAEB II type of myelodysplastic syndrome associated with axillary abscesses - Case Report.
Journal: Annals of agricultural and environmental medicine : AAEM
Published: December 31, 2021
Rare case of Richter's syndrome localization in liver and thyroid of a patient with a chronic lymphocytic leukemia (CLL) - Case report and literature.
Journal: Annals of agricultural and environmental medicine : AAEM
Published: March 27, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026